Harvard and Merck Team to Find Immuno-Oncology Targets

Harvard and Merck Team to Find Immuno-Oncology Targets »

  Check-point inhibitors and other immunotherapies have revolutionized the treatment of some cancers. But some patients do not respond at all – and others develop resistance to the drugs. Now Harvard University and Merck experts are teaming up to discover the reason why, down to the molecule and gene. The projected four-year undertaking will be…
Patients Driving Innovations In Cancer Care

Patients Driving Innovations In Cancer Care »

The 2016 World Medical Innovation Forum hosted by Partners HealthCare highlighted emerging approaches for diagnosing, treating and managing cancer. On the final day of the conference, patient advocacy leaders discussed the role that patients and philanthropy organizations plays in driving these innovations in cancer care.

Liquid Biopsies Could Make Cancer a Manageable Disease

Liquid Biopsies Could Make Cancer a Manageable Disease »

1 May, 2015
NewsUncategorized
Could a simple blood test revolutionize cancer detection and treatment? Photo via Shawn Hempel/ Shutterstock. The future of cancer treatment is here. A new technology in cancer detection and monitoring called the liquid biopsy (or circulating tumor cell (CTC) count) can detect tumor DNA circulating in the blood before symptoms even…
Changing the Cancer Care Paradigm: Team OnClass Heads to Google Cambridge

Changing the Cancer Care Paradigm: Team OnClass Heads to Google Cambridge »

14 Apr, 2015
PeopleUncategorized
Team Members (L to R): Sameer Massand, Ajay Kohli, Maxwell Henderson, Sarah Foster, Katja Engetschwiler, Trevor Heins, Benjamin Ehrlich, Jacob Zeitzew, Anita Ramoliya, Ajit Kohli "Few moments can be tougher for patients than receiving a diagnosis of cancer," says Wearables in Healthcare Pilot Challenge finalist Ajay Kohli. "As clinicians, we want…
Precision Medicine: Sounds Good, Right?

Precision Medicine: Sounds Good, Right? »

9 Feb, 2015
Opinion/Editorial
Will Obama's new precision medicine initiative really make a difference? Photo via Shutterstock. In his January 20, 2015 State of the Union Address, Barack Obama announced that he was “launching a new Precision Medicine Initiative….” In a more detailed conference on the 30th, he described precision medicine as “delivering the right…
Risk Factors & Research: A Conversation with Dr. Wendy Chen, Breast Cancer Specialist

Risk Factors & Research: A Conversation with Dr. Wendy Chen, Breast Cancer Specialist »

26 Jan, 2015
PeopleUncategorized
Dr. Wendy Chen, a breast cancer specialist at Dana Farber. Dr. Wendy Chen sees the world of breast cancer from two vantage points: from the bird’s eye view of an epidemiologist, scoping out global trends in the risk factors that cause cancer and disease; as well as from the ground-floor perspective of…

Send this to a friend